6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid

C94H95BBr3N23O2 — CID 161382759

IUPAC6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid
SMILESC=C(C)c1cnc2c(Br)nc(Br)cn12.C=C(C)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(-c3cncc(C)c3)cn12.C=C(C)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(Br)cn12.Cc1cncc(-c2cn3c(C(C)C)cnc3c(NCCc3c[nH]c4ccccc34)n2)c1.Cc1cncc(B(O)O)c1.NCCc1c[nH]c2ccccc12
InChIInChI=1S/C25H26N6.C25H24N6.C19H18BrN5.C10H12N2.C9H7Br2N3.C6H8BNO2/c2*1-16(2)23-14-29-25-24(27-9-8-18-13-28-21-7-5-4-6-20(18)21)30-22(15-31(23)25)19-10-17(3)11-26-12-19;1-12(2)16-10-23-19-18(24-17(20)11-25(16)19)21-8-7-13-9-22-15-6-4-3-5-14(13)15;11-6-5-8-7-12-10-4-2-1-3-9(8)10;1-5(2)6-3-12-9-8(11)13-7(10)4-14(6)9;1-5-2-6(7(9)10)4-8-3-5/h4-7,10-16,28H,8-9H2,1-3H3,(H,27,30);4-7,10-15,28H,1,8-9H2,2-3H3,(H,27,30);3-6,9-11,22H,1,7-8H2,2H3,(H,21,24);1-4,7,12H,5-6,11H2;3-4H,1H2,2H3;2-4,9-10H,1H3
InChIKeyVRXYEJDGHBZHQO-UHFFFAOYSA-N
MW1829.48 g/mol
LogP19.31
Rot. Bonds21

About 6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid

6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid (PubChem CID 161382759) has the molecular formula C94H95BBr3N23O2 and a molecular weight of 1829.48 g/mol. Its IUPAC name is 6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid.

Molecular Properties

Compound Name6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid
PubChem CID161382759
Molecular FormulaC94H95BBr3N23O2
Molecular Weight1829.48 g/mol
Exact Mass1825.57
IUPAC Name6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid
SMILESC=C(C)c1cnc2c(Br)nc(Br)cn12.C=C(C)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(-c3cncc(C)c3)cn12.C=C(C)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(Br)cn12.Cc1cncc(-c2cn3c(C(C)C)cnc3c(NCCc3c[nH]c4ccccc34)n2)c1.Cc1cncc(B(O)O)c1.NCCc1c[nH]c2ccccc12
InChIInChI=1S/C25H26N6.C25H24N6.C19H18BrN5.C10H12N2.C9H7Br2N3.C6H8BNO2/c2*1-16(2)23-14-29-25-24(27-9-8-18-13-28-21-7-5-4-6-20(18)21)30-22(15-31(23)25)19-10-17(3)11-26-12-19;1-12(2)16-10-23-19-18(24-17(20)11-25(16)19)21-8-7-13-9-22-15-6-4-3-5-14(13)15;11-6-5-8-7-12-10-4-2-1-3-9(8)10;1-5(2)6-3-12-9-8(11)13-7(10)4-14(6)9;1-5-2-6(7(9)10)4-8-3-5/h4-7,10-16,28H,8-9H2,1-3H3,(H,27,30);4-7,10-15,28H,1,8-9H2,2-3H3,(H,27,30);3-6,9-11,22H,1,7-8H2,2H3,(H,21,24);1-4,7,12H,5-6,11H2;3-4H,1H2,2H3;2-4,9-10H,1H3
InChIKeyVRXYEJDGHBZHQO-UHFFFAOYSA-N
XLogP19.31
TPSA325.16 Ų
H-Bond Donors10
H-Bond Acceptors21
Rotatable Bonds21
Heavy Atoms123
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001829.48
LogP ≤ 519.31
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-[4-Pyridin-4-yl-6-[6-pyridin-2-yl-4-(4-pyrido[4,3-b]indol-5-ylphenyl)-2-pyridinyl]-2-pyridinyl]pyrido[4,3-b]indole;5-[6-[6-pyridin-4-yl-4-(4-pyrido[2,3-b]indol-9-ylphenyl)-2-pyridinyl]-2-pyridinyl]pyrido[4,3-b]indole;5-[2-pyridin-2-yl-6-(6-pyrido[3,4-b]indol-9-yl-2-pyridinyl)-4-pyridinyl]pyrido[3,2-b]indole;9-[6-[4-(4-pyrido[3,4-b]indol-9-ylphenyl)-6-[6-(trifluoromethyl)-2-pyridinyl]-2-pyridinyl]-2-pyridinyl]pyrido[3,4-b]indole
CID 157772108
1-chloro-4-[(2S)-1-methylpyrrolidin-2-yl]-9H-pyrido[3,4-b]indole;1,9-dimethyl-4-[(2S)-1-methylpyrrolidin-2-yl]pyrido[3,4-b]indole;1-methyl-4-[(2S)-1-methylpyrrolidin-2-yl]-9H-pyrido[3,4-b]indole;9-methyl-3-[(2S)-1-methylpyrrolidin-2-yl]pyrido[2,3-b]indole;3-[(2S)-1-methylpyrrolidin-2-yl]-9H-pyrido[2,3-b]indole;3-[(2S)-1-methylpyrrolidin-2-yl]-4-(trifluoromethyl)-9H-pyrido[2,3-b]indole
CID 157781785
7-benzyl-6-methylidene-2-propoxy-5H-pyrrolo[2,3-d]pyrimidin-4-amine;7-benzyl-6-methylidene-2-(trifluoromethyl)-5H-pyrrolo[2,3-d]pyrimidin-4-amine;8-bromo-2-N-butyl-9-[(4-ethylphenyl)methyl]purine-2,6-diamine;2-N-butyl-9-[(4-ethylphenyl)methyl]purine-2,6-diamine;2-N-butyl-7H-purine-2,6-diamine;3,13-dimethyl-1,9,12-triaza-4-azoniatetracyclo[6.5.2.04,15.011,14]pentadeca-4,6,8(15),9,11(14),12-hexaen-10-amine
CID 158354929
7-(1-Ethylpiperidin-4-yl)-2-(4-fluorophenyl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]pyridine;3-(2-ethylpyrimidin-4-yl)-2-(4-fluorophenyl)-7-(1-methylpiperidin-4-yl)imidazo[1,2-a]pyridine;2-(4-fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]pyridine;2-(4-fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-pyrimidin-4-ylimidazo[1,2-a]pyridine;2-(4-fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-[2-(trifluoromethyl)pyrimidin-4-yl]imidazo[1,2-a]pyridine;2-(4-fluorophenyl)-3-(2-methylpyrimidin-4-yl)-7-piperidin-4-ylimidazo[1,2-a]pyridine
CID 159241490
2-[3,5-bis[3-[2-(trifluoromethyl)phenyl]imidazo[4,5-b]pyridin-2-yl]phenyl]-3-[2-(trifluoromethyl)phenyl]imidazo[4,5-b]pyridine;3-(2,6-dimethylphenyl)-2-[3-[3-(2,6-dimethylphenyl)-1H-imidazo[4,5-b]pyridin-3-ium-2-yl]-5-[3-(2,6-dimethylphenyl)imidazo[4,5-b]pyridin-2-yl]phenyl]imidazo[4,5-b]pyridine;3-(2,3,4,5,6-pentafluorophenyl)-2-[3-[3-(2,3,4,5,6-pentafluorophenyl)imidazo[4,5-b]pyridin-2-yl]-5-[3-(2,3,4,5,6-pentafluorophenyl)-1H-pyrrolo[3,2-b]pyridin-2-yl]phenyl]imidazo[4,5-b]pyridine
CID 159501331
7-tert-butyl-6,8-dihydro-5H-imidazo[1,5-a]pyrazine;7-tert-butyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;7-tert-butyl-3-ethyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;7-tert-butyl-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;5-tert-butyl-3,4,6,7-tetrahydroimidazo[4,5-c]pyridine;7-tert-butyl-3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;methane;1-methyl-3-propan-2-ylindole;3-propan-2-yl-1H-indole
CID 160579337
3-bromo-2-(2,6-diethylphenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridine;3-bromo-2-(2,6-diethylphenyl)-5-[5-(trifluoromethyl)pyrimidin-2-yl]-4,5,6,7-tetrahydroindazole;2-chloro-5-(trifluoromethyl)pyrimidine;2-(2,6-diethylphenyl)-3-(1H-indol-5-yl)-5-[5-(trifluoromethyl)pyrimidin-2-yl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine;1H-indol-5-ylboronic acid;hydrochloride
CID 160857203
7-benzyl-6-methylidene-2-propoxy-5H-pyrrolo[2,3-d]pyrimidin-4-amine;1-benzyl-2-methylidene-6-(trifluoromethyl)-3H-pyrrolo[3,2-c]pyridin-4-amine;8-bromo-2-N-butyl-9-[(4-ethylphenyl)methyl]purine-2,6-diamine;2-N-butyl-9-[(4-ethylphenyl)methyl]purine-2,6-diamine;2-N-butyl-6-methylidene-7-[(6-methyl-3-pyridinyl)methyl]-5H-pyrrolo[2,3-d]pyrimidine-2,4-diamine;2-N-butyl-7H-purine-2,6-diamine;3,13-dimethyl-1,9,12-triaza-4-azoniatetracyclo[6.5.2.04,15.011,14]pentadeca-4,6,8(15),9,11(14),12-hexaen-10-amine
CID 161963882
2-[(2R,6S)-1-ethyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1-[(1-methylpiperidin-4-yl)methyl]benzimidazole;2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1-[(1-propan-2-ylpiperidin-4-yl)methyl]benzimidazole;2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]benzimidazole;1-[(1-methylpiperidin-4-yl)methyl]-2-[(2R,6S)-6-(3-methyl-2-pyridinyl)-1-(2,2,2-trifluoroethyl)piperidin-2-yl]benzimidazole;2-[(2R,6S)-6-(3-methyl-2-pyridinyl)-1-(2-pyridin-2-ylethyl)piperidin-2-yl]-1H-benzimidazole
CID 161965105
4-bromo-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1-[(1-methylpiperidin-4-yl)methyl]benzimidazole;7-bromo-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-1-[(1-methylpiperidin-4-yl)methyl]benzimidazole;2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-4-(3-methylpiperazin-1-yl)-1H-benzimidazole;2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-7-(4-methylpiperazin-1-yl)-1-(2,2,2-trifluoroethyl)benzimidazole;4-(4-methylpiperazin-1-yl)-2-[(2R,6S)-1-methyl-6-(3-propan-2-yl-2-pyridinyl)piperidin-2-yl]-1H-benzimidazole
CID 163714694
N-[2-(1,1-difluoroethyl)-4-pyridinyl]-9-propan-2-yl-2-pyridin-4-ylpurin-6-amine;N,2-diphenyl-7H-purin-6-amine;6-methyl-N,2-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine;6-methyl-N,4-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-2-amine;9-propan-2-yl-2-pyridin-2-yl-N-[2-(trifluoromethyl)-4-pyridinyl]purin-6-amine
CID 165095474
2-(6-Tert-butyl-5-fluoro-3-pyridinyl)pyrimido[1,2-a]benzimidazole;2-(4-tert-butylpiperidin-1-yl)pyrimido[1,2-a]benzimidazole;2-(6-tert-butyl-3-pyridinyl)-7,8-difluoropyrimido[1,2-a]benzimidazole;2-(6-tert-butyl-3-pyridinyl)pyrimido[1,2-a]benzimidazole;2-[6-tert-butyl-5-(trifluoromethyl)-3-pyridinyl]pyrimido[1,2-a]benzimidazole;2-methylpropane;2-piperazin-1-ylpyrimido[1,2-a]benzimidazole
CID 167543321

Frequently Asked Questions

What is the IUPAC name of 6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid?
The IUPAC name of 6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid (CID 161382759) is 6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid.
What is the SMILES notation for 6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid?
The canonical SMILES for 6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid is C=C(C)c1cnc2c(Br)nc(Br)cn12.C=C(C)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(-c3cncc(C)c3)cn12.C=C(C)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(Br)cn12.Cc1cncc(-c2cn3c(C(C)C)cnc3c(NCCc3c[nH]c4ccccc34)n2)c1.Cc1cncc(B(O)O)c1.NCCc1c[nH]c2ccccc12.
What is the InChIKey of 6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid?
The InChIKey is VRXYEJDGHBZHQO-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H26N6.C25H24N6.C19H18BrN5.C10H12N2.C9H7Br2N3.C6H8BNO2/c2*1-16(2)23-14-29-25-24(27-9-8-18-13-28-21-7-5-4-6-20(18)21)30-22(15-31(23)25)19-10-17(3)11-26-12-19;1-12(2)16-10-23-19-18(24-17(20)11-25(16)19)21-8-7-13-9-22-15-6-4-3-5-14(13)15;11-6-5-8-7-12-10-4-2-1-3-9(8)10;1-5(2)6-3-12-9-8(11)13-7(10)4-14(6)9;1-5-2-6(7(9)10)4-8-3-5/h4-7,10-16,28H,8-9H2,1-3H3,(H,27,30);4-7,10-15,28H,1,8-9H2,2-3H3,(H,27,30);3-6,9-11,22H,1,7-8H2,2H3,(H,21,24);1-4,7,12H,5-6,11H2;3-4H,1H2,2H3;2-4,9-10H,1H3.
What are the key properties of 6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid?
6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid has a molecular weight of 1829.48 g/mol, XLogP of 19.31, 21 rotatable bonds, 10 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;6,8-dibromo-3-prop-1-en-2-ylimidazo[1,2-a]pyrazine;2-(1H-indol-3-yl)ethanamine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-propan-2-ylimidazo[1,2-a]pyrazin-8-amine;N-[2-(1H-indol-3-yl)ethyl]-6-(5-methyl-3-pyridinyl)-3-prop-1-en-2-ylimidazo[1,2-a]pyrazin-8-amine;(5-methyl-3-pyridinyl)boronic acid is sourced from PubChem (CID 161382759), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).